Departmental Regulations Respecting Licensed Pharmacists


Canada Customs and Revenue Agency, Circular 207-1, Oct. 1995

These Regulations were made by the Minister of National Revenue, on November 18, 1976, pursuant to section 31 and 191 of the Excise Act (Registration No. SOR/76/773. November 19, 1976)

SHORT TITLE
1. These Regulations may be cited as the Pharmacists Regulations.

INTERPRETATION
2. In these Regulations,
"Act" means the Excise Act;
"licensed pharmacist" means a pharmacist licensed under section 136 of the Act.

RECORDS
3. Every licensed pharmacist shall record, in accordance with section 31 of the Act, in the stock books kept by him pursuant to that section, the following:
(a) particulars of each lot of spirits received by him from a distiller or a distiller's bonding warehouse or from a provincial liquor control board or commission, including
    (i) the date of receipt,
    (ii) the name and address of the supplier,
    (iii) the strength of the spirits received, and
    (iv) the quantity of spirits received; and
    (b) particulars of each operation in which the spirits are used, including
    (i) the date when used,
    (ii) the number of the prescription dispensed or the name of the pharmaceutical preparation made, and
    (iii) the quantity of spirits used.

RETURNS
4. Every licensed pharmacist shall at the close of each fiscal year submit to the regional director of excise a written statement setting out particulars of all transactions carried on by the pharmacist during the fiscal year, including
    (a) the inventory of spirits on hand at the beginning of the fiscal year;
    (b) the quantities of spirits received during the fiscal year;
    (c) the quantity of spirits taken for use plus any authorized credits;
    (d) the quantity of spirits found at stock-taking;
    (e) any deficiencies found at stock-taking; and
    (f) the cause of deficiencies found at stock-taking.

ABATEMENT UPON DEFICIENCIES
5. A regional director of excise may, at the close of a fiscal year, allow an abatement under subsection 191(2) of the Act upon deficiencies found at stock-taking by a licensed pharmacist upon receipt from the pharmacist of a written statement submitted pursuant to section 4.